| Literature DB >> 31970328 |
Ece Cetin1, Seran Temelli2, Aysegul Eyigor2.
Abstract
This study aimed to determine the current prevalence, serovar distribution and antimicrobial resistance rate and patterns of nontyphoid Salmonella (NTS) in slaughter sheep and their edible offal. While filling the gap of up to date related information in Turkey, data presented is also of significance since contamination of ovine meat, its products and offal with this pathogen is threat to public health due to their considerably high consumption rates in our country. Current NTS carriage in 200 apparently healthy slaughter sheep by ISO 6579:2002, 6579:2002/A1:2007 standard bacteriology (ISO) was 5% (10/200) (4 fecal content - 2%, 3 mesenterial lymph node - 1.5%, 3 kidney - 1.5%) out of 1,400 samples (0.7%), with no isolation from carcass, liver, gallbladder, spleen. Real-time PCR was in substantial agreement to ISO in confirming Salmonella-suspect isolates (Relative Trueness: 93.6%). S. Newport (40%) was the predominant serovar, followed by the second prevalent serovars as S. Typhimurium and S. Kentucky (20%), and by S. Umbilo and S. Corvallis (10%). Four and 6 out of 10 NTS isolates were susceptible (40%) and resistant (60%) to 18 antimicrobials, respectively. S. Typhimurium isolates were multidrug resistant (MDR) to tigecycline and sulphamethoxazole/trimethoprim, with one also resistant to cefepime. S. Corvallis was MDR to ampicillin, ciprofloxacin, norfloxacin and pefloxacin. The predominance of S. Newport and first isolation of S. Corvallis in sheep in the world; first time isolations of Newport, Kentucky, Corvallis, Umbilo serovars from sheep in Turkey; and high antimicrobial resistance rates obtained in majority of the isolates highlights study findings. © Korean Society for Food Science of Animal Resources.Entities:
Keywords: ISO; antimicrobial resistance; nontyphoid Salmonella; serovar; sheep
Year: 2020 PMID: 31970328 PMCID: PMC6957453 DOI: 10.5851/kosfa.2019.e75
Source DB: PubMed Journal: Food Sci Anim Resour ISSN: 2636-0772
Primers, probes, and internal amplification control sequence used for Salmonella spp.-specific real-time PCR
| Designation | Sequence | Positions[ |
|---|---|---|
| ttr-6 (forward) | CTCACCAGGAGATTACAACATGG | 4287–4309 |
| ttr-4 (reverse) | AGCTCAGACCAAAAGTGACCATC | 4359–4381 |
| ttr-5 (target probe) | FAM-CACCGACGGCGAGACCGACTTT-TAMRA | |
| IAC sequence[ | ||
| IAC (forward) | CGTCAGTGTGAAGCGGTTATAA | |
| IAC (reverse) | ATGCCACGTAAGCGAAACA | |
| IAC probe | HEX-TGCTCTTTCGCGGTATCCGTACCGAT-TAMRA |
Positions correspond to Genbank accession no. AF282268.
The sequences marked in boldface type are the primer binding sites for IAC, and the underlined sequence is the reverse complement IAC probe binding site.
IAC, internal amplification control.
Antimicrobials used in this study for testing susceptibility of the isolates
| NO | Name (Abbreviation, quantity on disk,
catalog no)[ |
|---|---|
| 1 | Amikacin (AK, 30 μg, CT0107B) |
| 2 | Amoxicillin/clavulanic acid (AMC, 30 μg, CT0223B) |
| 3 | Ampicillin (AMP, 10 μg, CT0003B) |
| 4 | Ampicillin/sulbactam 1:1 (SAM, 20 μg, CT0520B) |
| 5 | Azithromycin (AZM, 15 μg, CT0906B) |
| 6 | Ciprofloxacin (CIP, 1 μg, CT0623B) |
| 7 | Cefepime (FEP, 30 μg, CT0771B) |
| 8 | Cefotaxime (CTX, 30 μg, CT0166B) |
| 9 | Cefoxitin (FOX, 30 μg, CT0119B) |
| 10 | Chloramphenicol (C, 30 μg, CT0013B) |
| 11 | Ertapenem (ETP, 10 μg, CT1761B) |
| 12 | Gentamicin (CN, 120 μg, CT0794B) |
| 13 | Norfloxacin (NOR, 10 μg, CT0434B) |
| 14 | Pefloxacin (PEF, 5 μg, CT0661B) |
| 15 | Piperacillin/tazobactam (TZP, 110 μg, CT0725B) |
| 16 | Sulphamethoxazole/trimethoprim 19:1 (SXT, 25 μg, CT0052B) |
| 17 | Tigecycline (TGC, 15 μg, CT1841B) |
| 18 | Tobramycin (TOB, 10 μg, CT0056B) |
All disks had the same brand as Oxoid.
Prevalence, serovar distribution and antimicrobial resistance profile of Salmonella in slaughter sheep
| Sample type (n) | Number of positive samples (%) | Sample ID | Serovar | Resistance profile |
|---|---|---|---|---|
| Carcass (200) | 0 (0.0) | |||
| Fecal content (200) | 4 (2.0) | F111 | Newport | TGC |
| F112 | Newport | - | ||
| F214 | Newport | PEF | ||
| F247 | Typhimurium | TGC, SXT | ||
| Mesenteric lymph node (200) | 3 (1.5) | M116 | Newport | TOB |
| M247 | Umbilo | - | ||
| M248 | Typhimurium | FEP, TGC, SXT | ||
| Liver (200) | 0 (0.0) | |||
| Kidney (200) | 3 (1.5) | K42 | Corvallis | AMP, CIP, NOR, PEF |
| K192 | Kentucky | - | ||
| K267 | Kentucky | - | ||
| Spleen (200) | 0 (0.0) | |||
| Gallbladder (200) | 0 (0.0) | |||
| Total (1,400) | 10 (0.7) |